MoneyBloomberg Technology
Immunology Drugmaker Electra Opens Flat After Upsized US IPO
Electra Therapeutics Inc., a clinical-stage developer of immunology drugs, opened at its IPO price on Friday after raising $350 million in an upsized US offering.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Electra Therapeutics Inc., a clinical-stage developer of immunology drugs, opened at its IPO price on Friday after raising $350 million in an upsized US offering.
Join the argument
House rules →Comments load as you scroll.